Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.
暂无分享,去创建一个
Jonathan Rasmussen | Yuxiao Zhou | Xiaoyuan Ji | Morteza Mahmoudi | Wei Tao | Jinjun Shi | Omid C. Farokhzad | Yuxiao Zhou | O. Farokhzad | M. Mahmoudi | X. Ji | Yujing Li | Wei Tao | Jinjun Shi | P. Saw | M. Yu | Xiao-Ding Xu | Phei Er Saw | Dana Ayyash | D. Ayyash | Jonathan Rasmussen | Xiaoding Xu | Yujing Li | Mi Kyung Yu
[1] William Y. Kim,et al. Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[2] Jin-Zhi Du,et al. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. , 2012, ACS nano.
[3] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[4] Q. Ping,et al. Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration. , 2014, Angewandte Chemie.
[5] Mauro Ferrari,et al. An injectable nanoparticle generator enhances delivery of cancer therapeutics , 2016, Nature Biotechnology.
[6] R. Young,et al. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.
[7] V. Préat,et al. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. , 2012, Molecular pharmaceutics.
[8] Xian‐Zheng Zhang,et al. Controlled peptide coated nanostructures via the self-assembly of functional peptide building blocks , 2012 .
[9] Shwu‐Yuan Wu,et al. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. , 2013, Molecular cell.
[10] Zhaohui S. Qin,et al. Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer , 2014, Nature.
[11] L. Patterson,et al. RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis , 2012, Cancers.
[12] P. Kantoff,et al. Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.
[13] Jonathan Rasmussen,et al. Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. , 2017, ACS nano.
[14] R. Vessella,et al. Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.
[15] Qingqing Yang,et al. Multistage Nanovehicle Delivery System Based on Stepwise Size Reduction and Charge Reversal for Programmed Nuclear Targeting of Systemically Administered Anticancer Drugs , 2015 .
[16] Omid C Farokhzad,et al. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy. , 2016, Angewandte Chemie.
[17] M. Sporn,et al. The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.
[18] Robert Langer,et al. Impact of nanotechnology on drug delivery. , 2009, ACS nano.
[19] Ronnie H. Fang,et al. Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery , 2014, Nano letters.
[20] Leaf Huang,et al. Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[21] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[22] Jun Wang,et al. Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration. , 2016, ACS nano.
[23] U. Schubert,et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.
[24] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[25] Yu-cheng Tseng,et al. Lipid-based systemic delivery of siRNA. , 2009, Advanced drug delivery reviews.
[26] F. Howe,et al. Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.
[27] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[28] Zhen Gu,et al. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. , 2014, Chemical Society reviews.
[29] Baran D. Sumer,et al. A Broad Nanoparticle-Based Strategy for Tumor Imaging by Nonlinear Amplification of Microenvironment Signals , 2013, Nature materials.
[30] Izhak Haviv,et al. Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.
[31] Jinho Park,et al. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.
[32] Dai Fukumura,et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.
[33] Jinming Gao,et al. Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. , 2011, Angewandte Chemie.
[34] Daniel S. Kohane,et al. Photoswitchable nanoparticles for in vivo cancer chemotherapy , 2013, Proceedings of the National Academy of Sciences.
[35] J. Brady,et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. , 2005, Molecular cell.
[36] Y. Lim,et al. Controlled bioactive nanostructures from self-assembly of peptide building blocks. , 2007, Angewandte Chemie.
[37] Jill P. Mesirov,et al. Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 , 2012, Science Translational Medicine.
[38] Noritada Kaji,et al. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid. , 2011, Biomaterials.
[39] Qiang Zhang,et al. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment , 2017, Theranostics.
[40] Xiaoyuan Chen,et al. Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization , 2016, Advanced materials.
[41] Jin-Zhi Du,et al. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. , 2011, Journal of the American Chemical Society.
[42] Jun Wang,et al. Matrix metalloproteinase 2-responsive micelle for siRNA delivery. , 2014, Biomaterials.
[43] Mark E. Davis,et al. Clinical experiences with systemically administered siRNA-based therapeutics in cancer , 2015, Nature Reviews Drug Discovery.
[44] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[45] I. Wistuba,et al. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment , 2015, Proceedings of the National Academy of Sciences.
[46] Zhen Gu,et al. Programmable nanomedicine: synergistic and sequential drug delivery systems. , 2015, Nanoscale.
[47] Song Shen,et al. Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery. , 2015, Journal of the American Chemical Society.
[48] Zheng-Rong Lu,et al. Targeted Dual pH‐Sensitive Lipid ECO/siRNA Self‐Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy , 2016, Advanced healthcare materials.
[49] Tristan Barrett,et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes , 2009, Nature Medicine.
[50] Leaf Huang,et al. In vivo gene delivery by nonviral vectors: overcoming hurdles? , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] Daniel Anderson,et al. Delivery materials for siRNA therapeutics. , 2013, Nature materials.
[52] Xiaoyuan Chen,et al. Stimuli-Responsive Programmed Specific Targeting in Nanomedicine. , 2016, ACS nano.
[53] Robert Langer,et al. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures , 2017, Expert opinion on drug delivery.
[54] Véronique Préat,et al. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[55] R. Raines,et al. Internalization of cationic peptides: the road less (or more?) traveled , 2006, Cellular and Molecular Life Sciences CMLS.
[56] Daniel G. Anderson,et al. Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.
[57] Qiang Zhou,et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. , 2005, Molecular cell.
[58] Jun Wang,et al. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.